Soleno Therapeutics(SLNO) - 2025 Q3 - Quarterly Report
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 77-0523891 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 100 Marine Parkway, Suite 400 Redwood City, California (Address of principal executive offices) 94065 (Zip Code) (650) 213-8444 (Registrant's telephone number, including area code) For the quarterly period ended ...